Rise Advisors’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-191
Closed -$38.8K – 1293
2025
Q3
$38.8K Buy
191
+3
+2% +$532 0.01% 310
2025
Q2
$33.1K Sell
188
-8
-4% -$1.2K 0.01% 321
2025
Q1
$26.4K Sell
196
-79
-29% -$10.4K 0.01% 367
2024
Q4
$34.7K Hold
275
– – 0.02% 330
2024
Q3
$45.7K Hold
275
– – 0.02% 256
2024
Q2
$36.6K Hold
275
– – 0.02% 303
2024
Q1
$28.9K Buy
+275
New +$24.7K 0.02% 396
2023
Q2
– Sell
-50
Closed -$2.97K – 793
2023
Q1
$2.97K Hold
50
– – ﹤0.01% 522
2022
Q4
$2.44K Hold
50
– – ﹤0.01% 535
2022
Q3
$3K Buy
+50
New +$2.97K ﹤0.01% 513

Other funds holding THC

Rise Advisors's THC Position: Q4 2025 in Review

Rise Advisors sold out of Tenet Healthcare (THC) in Q4 2025, closing a stake of 191 shares — an estimated $38.8K sold.

Rise Advisors first reported a position in THC in Q3 2022 and held it in 10 quarters. The position peaked at $45.7K in Q3 2024. 705 funds tracked by Wall St. Rank hold THC as of Q4 2025.

  • Rise Advisors reported no remaining Tenet Healthcare position as of Q4 2025 after selling out during the quarter.
  • Rise Advisors sold 191 Tenet Healthcare shares in Q4 2025, an estimated $38.8K.
  • Rise Advisors first reported a position in Tenet Healthcare in Q3 2022 and held it in 10 quarters.
  • Rise Advisors's Tenet Healthcare position peaked at $45.7K in Q3 2024.
  • 705 funds tracked by Wall St. Rank held Tenet Healthcare as of Q4 2025.

Based on Rise Advisors's 13F filing for Q4 2025, filed 11 Feb 2026.